The Impact of Gray Matter Structural Changes on Clinical Disability in Multiple Sclerosis: Voxel-and Surface-Based Analyses

Aglamis, S., Murat Aydin, A., Eroglu, Y., Burakgazi, G., & Atmaca, M. (2021). Diffusion-weighted MRI findings of caudate nucleus and putamen in patients with obsessive-compulsive disorder. Cureus, 13, e17023.

PubMed  PubMed Central  Google Scholar 

Al-Radaideh, A., Athamneh, I., Alabadi, H., & Hbahbih, M. (2021). Deep Gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI). European Radiology, 31, 706–715.

PubMed  Google Scholar 

Benedict, R. H., Carone, D. A., & Bakshi, R. (2004). Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. Journal of Neuroimaging, 14, 36S–45S.

PubMed  Google Scholar 

Chard, D. T., & Miller, D. H. (2016) What Lies beneath grey matter atrophy in multiple sclerosis? Brain 139 7–10.

PubMed  Google Scholar 

Eshaghi, A., et al. (2018a). Deep Gray matter volume loss drives disability worsening in multiple sclerosis. Annals of Neurology, 83, 210–222.

CAS  PubMed  PubMed Central  Google Scholar 

Eshaghi, A., et al. (2018b). Progression of regional grey matter atrophy in multiple sclerosis. Brain, 141, 1665–1677.

PubMed  PubMed Central  Google Scholar 

Etemadifar, M., & Sabeti, F. (2018). Applying the 2017 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurology, 17, 497.

PubMed  Google Scholar 

Fiore, A., et al. (2023). Correspondence among Gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis. Molecular Psychiatry, 28, 1770–1782.

CAS  PubMed  Google Scholar 

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.

CAS  PubMed  Google Scholar 

Fujimori, J., Fujihara, K., Wattjes, M., & Nakashima, I. (2021). Patterns of cortical grey matter thickness reduction in multiple sclerosis. Brain Behav, 11, e02050.

CAS  PubMed  PubMed Central  Google Scholar 

Hamilton, M. (1959). The assessment of anxiety States by rating. British Journal of Medical Psychology, 32, 50–55.

CAS  PubMed  Google Scholar 

Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.

CAS  PubMed  PubMed Central  Google Scholar 

Han, J., et al. (2024). A study of the correlation between Gray matter atrophy in multiple sclerosis and impairment of cognitive function domains. Zhonghua Nei Ke Za Zhi, 63, 666–673.

CAS  PubMed  Google Scholar 

Katz Sand, I. (2015). Classification, diagnosis, and differential diagnosis of multiple sclerosis. Current Opinion in Neurology, 28, 193–205.

PubMed  Google Scholar 

Kaufman, M., Moyer, D., & Norton, J. (2000). The significant change for the timed 25-foot walk in the multiple sclerosis functional composite. Multiple Sclerosis (Houndmills, Basingstoke, England), 6, 286–290.

CAS  PubMed  Google Scholar 

Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33, 1444–1452.

CAS  PubMed  Google Scholar 

Lorefice, L., et al. (2020). The impact of deep grey matter volume on cognition in multiple sclerosis. Mult Scler Relat Disord, 45, 102351.

CAS  PubMed  Google Scholar 

Nasreddine, Z. S., et al. (2005). The Montreal cognitive assessment, moca: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695–699.

PubMed  Google Scholar 

Nygaard, M. K. E., Riemenschneider, M., Gaemelke, T., Dalgas, U., & Eskildsen, S. F. (2025). Spatiotemporal alterations of Gray matter microstructure in newly diagnosed relapsing-remitting multiple sclerosis patients: A longitudinal diffusion kurtosis MRI study. Journal of the Neurological Sciences, 474, 123551.

PubMed  Google Scholar 

Panahzadeh, F., Mirnasuri, R., & Rahmati, M. (2022). Exercise and Syzygium aromaticum reverse memory deficits, apoptosis and mitochondrial dysfunction of the hippocampus in alzheimer’s disease. Journal of Ethnopharmacology, 286, 114871.

CAS  PubMed  Google Scholar 

Perez, C. A., Cuascut, F. X., & Hutton, G. J. (2023). Immunopathogenesis, diagnosis, and treatment of multiple sclerosis: A clinical update. Neurologic Clinics, 41, 87–106.

PubMed  Google Scholar 

Rocca, M. A., et al. (2010). Thalamic damage and long-term progression of disability in multiple sclerosis. Radiology, 257, 463–469.

PubMed  Google Scholar 

Sastre-Garriga, J., et al. (2020). MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nat Rev Neurol, 16, 171–182.

PubMed  PubMed Central  Google Scholar 

Schoonheim, M. M., et al. (2015). Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology, 84, 776–783.

PubMed  Google Scholar 

Tryfonos, C. (2023). Association of higher mediterranean diet adherence with lower prevalence of disability and symptom severity, depression, anxiety, stress, sleep quality, cognitive impairment, and physical inactivity in older adults with multiple sclerosis. J Geriatr Psychiatry Neurol, 8919887231218754.

Zhang, J., et al. (2024). Abnormal caudate nucleus activity in patients with depressive disorder: Meta-analysis of task-based functional magnetic resonance imaging studies with behavioral domain. Psychiatry Res Neuroimaging, 338, 111769.

PubMed  Google Scholar 

Comments (0)

No login
gif